Having trouble accessing articles? Reset your cache.

Zactima vandetanib: Phase II data

In the double-blind Phase II ZACTHYF trial in 145 patients who failed treatment with or were unsuitable for treatment with radioiodine therapy, once-daily 300 mg oral Zactima met the

Read the full 294 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE